7-16463435-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015464.3(SOSTDC1):​c.206-472G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.502 in 151,784 control chromosomes in the GnomAD database, including 20,630 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.50 ( 20630 hom., cov: 32)

Consequence

SOSTDC1
NM_015464.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00400

Publications

3 publications found
Variant links:
Genes affected
SOSTDC1 (HGNC:21748): (sclerostin domain containing 1) This gene is a member of the sclerostin family and encodes an N-glycosylated, secreted protein with a C-terminal cystine knot-like domain. This protein functions as a bone morphogenetic protein (BMP) antagonist. Specifically, it directly associates with BMPs, prohibiting them from binding their receptors, thereby regulating BMP signaling during cellular proliferation, differentiation, and programmed cell death. [provided by RefSeq, Jul 2008]
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
CRPPA Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • myopathy caused by variation in CRPPA
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2U
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy without intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.608 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015464.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SOSTDC1
NM_015464.3
MANE Select
c.206-472G>A
intron
N/ANP_056279.1Q6X4U4-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SOSTDC1
ENST00000307068.5
TSL:1 MANE Select
c.206-472G>A
intron
N/AENSP00000304930.4Q6X4U4-1
CRPPA
ENST00000675257.1
c.-47+32945G>A
intron
N/AENSP00000501664.1A0A6Q8PF75
CRPPA
ENST00000674759.1
c.-47+32945G>A
intron
N/AENSP00000502749.1A0A6Q8PHI3

Frequencies

GnomAD3 genomes
AF:
0.502
AC:
76175
AN:
151666
Hom.:
20626
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.299
Gnomad AMI
AF:
0.797
Gnomad AMR
AF:
0.558
Gnomad ASJ
AF:
0.525
Gnomad EAS
AF:
0.423
Gnomad SAS
AF:
0.441
Gnomad FIN
AF:
0.535
Gnomad MID
AF:
0.573
Gnomad NFE
AF:
0.612
Gnomad OTH
AF:
0.519
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.502
AC:
76212
AN:
151784
Hom.:
20630
Cov.:
32
AF XY:
0.497
AC XY:
36873
AN XY:
74172
show subpopulations
African (AFR)
AF:
0.298
AC:
12339
AN:
41352
American (AMR)
AF:
0.558
AC:
8518
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.525
AC:
1819
AN:
3462
East Asian (EAS)
AF:
0.424
AC:
2183
AN:
5152
South Asian (SAS)
AF:
0.442
AC:
2119
AN:
4796
European-Finnish (FIN)
AF:
0.535
AC:
5638
AN:
10532
Middle Eastern (MID)
AF:
0.571
AC:
168
AN:
294
European-Non Finnish (NFE)
AF:
0.612
AC:
41608
AN:
67932
Other (OTH)
AF:
0.520
AC:
1093
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1854
3708
5561
7415
9269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
668
1336
2004
2672
3340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.551
Hom.:
3797
Bravo
AF:
0.496
Asia WGS
AF:
0.423
AC:
1467
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
1.0
DANN
Benign
0.50
PhyloP100
0.0040
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs12699800; hg19: chr7-16503060; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.